Autoimmune Responses to Amyloid Structures of Aβ(25–35) Peptide and Human Lysozyme in the Serum of Patients with Progressive Alzheimer’s Disease

Publisher： Karger

E-ISSN： 1421-9824|18|2|165-171

ISSN： 1420-8008

Source： Dementia and Geriatric Cognitive Disorders, Vol.18, Iss.2, 2004-08, pp. : 165-171

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of Alzheimer’s Disease Using the CSF Aβ42/Aβ40 Ratio in Patients with Mild Cognitive Impairment

By  

Dementia and Geriatric Cognitive Disorders, Vol. 23, Iss. 5, 2007-03 ,pp. : 316-320

Karger

Access to resources Recommend Favorite

Patients with Alzheimer disease have lower levels of serum anti-amyloid peptide antibodies than healthy elderly individuals

By Weksler M.E.   Relkin N.   Turkenich R.   LaRusse S.   Zhou L.   Szabo P.  

Experimental Gerontology, Vol. 37, Iss. 7, 2002-07 ,pp. : 943-948

Elsevier

Access to resources Recommend Favorite

Ceruloplasmin and Iron Proteins in the Serum of Patients with Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 1, Iss. 1, 2011-11 ,pp. : 366-371

Karger

Access to resources Recommend Favorite

Age-Dependent Change in the Levels of Aβ40 and Aβ42 in Cerebrospinal Fluid from Control Subjects, and a Decrease in the Ratio of Aβ42 to Aβ40 Level in Cerebrospinal Fluid from Alzheimer’s Disease Patients

By  

European Neurology, Vol. 43, Iss. 3, 2000-04 ,pp. : 155-160

Karger

Access to resources Recommend Favorite

Oral Glucose Loading Modulates Plasma β-Amyloid Level in Alzheimer’s Disease Patients: Potential Diagnostic Method for Alzheimer’s Disease

By  

Dementia and Geriatric Cognitive Disorders, Vol. 34, Iss. 1, 2012-08 ,pp. : 25-30

Karger

Access to resources Recommend Favorite